Explore By Subject Area   
Return Home
Menu

Lead Podcast

The CMO as a Translational Scientist

The CMO as a Translational Scientist

Three biotech CMOs discuss how biotech CMOs can set their assets up for success before getting into the clinic, the key skills needed to bridge the scientific and clinical functions of the company and how to collaborate effectively with CSOs.

Learn More

Featured Podcasts

The History of Tumor Vaccines, and Why the Newest RNA Vaccines May Work Where Others Could Not

Listen

Applying an Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials

Listen

Combining AI and Empirical Science to Advance Cancer Immunotherapies

Listen

Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral Delivery

Listen

Maximizing Regulatory Interactions

Listen

Podcasts by Category

Clinical Trial Operations

View All
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles
Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles
Accessing a Novel Source of Patient Experience Data to Improve Clinical Research
Accessing a Novel Source of Patient Experience Data to Improve Clinical Research
Empathy and Behavioral Science in ePROs to Increase Data Collection Adherence
Empathy and Behavioral Science in ePROs to Increase Data Collection Adherence
Sponsored

Immuno-Oncology and Cell Therapy

View All
The CMO as a Translational Scientist
The CMO as a Translational Scientist
The History of Tumor Vaccines, and Why the Newest RNA Vaccines May Work Where Others Could Not
The History of Tumor Vaccines, and Why the Newest RNA Vaccines May Work Where Others Could Not
Combining AI and Empirical Science to Advance Cancer Immunotherapies
Combining AI and Empirical Science to Advance Cancer Immunotherapies
Getting Under the Hood of AI to Find Its Value for Immuno-Oncology
Getting Under the Hood of AI to Find Its Value for Immuno-Oncology

Drug Delivery

View All
Designing and Developing Drug Delivery for LMICs
Designing and Developing Drug Delivery for LMICs
Antiviral Drug Development: How NanoViricides is Overcoming Challenges to the Current Model
Antiviral Drug Development: How NanoViricides is Overcoming Challenges to the Current Model
Sponsored
Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral Delivery
Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral Delivery
Overcoming Barriers to Adoption of Transdermal Delivery
Overcoming Barriers to Adoption of Transdermal Delivery

Patients as Partners in Clinical Research and Patient Access

View All
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
Applying an Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials
Applying an Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials
Incorporating Quantitative Values of Patient Perspectives into Clinical Trial Design
Incorporating Quantitative Values of Patient Perspectives into Clinical Trial Design
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care

Biotech CMO/R&D Leadership

View All
CMO Misunderstandings about Clinical Operations and How to Improve
CMO Misunderstandings about Clinical Operations and How to Improve
The CMO as a Translational Scientist
The CMO as a Translational Scientist
Transitioning from Early Stage to Registrational/Pivotal Stage Development
Transitioning from Early Stage to Registrational/Pivotal Stage Development
Maximizing Regulatory Interactions
Maximizing Regulatory Interactions

CRAACO: Clinical Research as a Care Option

View All
Making Clinical Research a Feasible Care Option Using Modern Software Infrastructure
Making Clinical Research a Feasible Care Option Using Modern Software Infrastructure
Sponsored
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
The Personal Impact of a Clinical Trial
The Personal Impact of a Clinical Trial
Astellas’ Head of Patient Centricity on his New Book "A Bandana and a Bluebird," and Lessons from Patients for Medicine Development
Astellas’ Head of Patient Centricity on his New Book "A Bandana and a Bluebird," and Lessons from Patients for Medicine Development

Women Leadership in Biotech

View All
How Regeneron Got an FDA-Approved Therapy for COVID in Record Time
How Regeneron Got an FDA-Approved Therapy for COVID in Record Time
A Vision for the Integration of Clinical Research and Care
A Vision for the Integration of Clinical Research and Care
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
Innovative CRISPR Editing to Create Off-the-Shelf Immune Cell Therapies
Innovative CRISPR Editing to Create Off-the-Shelf Immune Cell Therapies

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.